- 1.2-1.5 USD ($)
- 1.20 - 1.50 USD ($)
This Access Bio COVID-19 Test Home Collection Kit- 2 Pack allows you to collect your sample in your home, with highly accurate results in less than 15 minutes. This test is available to help determine infection and limit the spread of Covid-19.
Collect your sample using the nasal swab, follow the directions for fast and easy use. This kit is indicated for children as young as 2 years old when administered by an adult, and for all people ages 14 and older to self-perform. This item is not covered in the Medicare program and this test is ineligible for Medicare reimbursement. This test is applicable to both symptomatic or asymptomatic individuals.
If you are experiencing severe symptoms that mimic those shared by the CDC, such as difficulty breathing or blue lips, please seek medical attention immediately. The CDC recommends calling your healthcare provider to understand next steps after receiving a positive result for COVID-19.
Content on this site is for reference purposes only. Target does not represent or warrant that the nutrition, ingredient, allergen and other product information on our Web or Mobile sites are accurate or complete, since this information comes from the product manufacturers. On occasion, manufacturers may improve or change their product formulas and update their labels. We recommend that you do not rely solely on the information presented on our Web or Mobile sites and that you review the product's label or contact the manufacturer directly if you have specific product concerns or questions. If you have specific healthcare concerns or questions about the products displayed, please contact your licensed healthcare professional for advice or answers.
This at-home Covid-19 testing kit has not been FDA cleared or approved, but it has been authorized by FDA under an EUA. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; and, This product is authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
- 3 Per Day
- 5-15 Days
- Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
- CareStart Covid-19 Antigen Home Test Kit in Saudi Arabia.FDA EUA CE ISO GMP SFC ETC.
28955, Avenue Sherman Valencia, California, Missouri, 91355, United States